Phosphorylation of 4E-BP1 in the Mammalian Brain Is Not Altered by LRRK2 Expression or Pathogenic Mutations

• Alzbeta Trancikova,

  Affiliation Brain Mind Institute, School of Life Sciences, Ecole Polytechnique Fédérale de Lausanne, Lausanne, Switzerland

  ⨯
• Adamantios Mamais,

  Affiliation Reta Lila Weston Institute of Neurological Disease, University College London Institute of Neurology, London, United Kingdom

  ⨯
• Philip J. Webber,

  Affiliation Center for Neurodegeneration and Experimental Therapeutics, Department of Neurology, University of Alabama at Birmingham, Birmingham, Alabama, United States of America

  ⨯
• Klodjan Stafa,

  Affiliation Brain Mind Institute, School of Life Sciences, Ecole Polytechnique Fédérale de Lausanne, Lausanne, Switzerland

  ⨯
• Elpida Tsika,

  Affiliation Brain Mind Institute, School of Life Sciences, Ecole Polytechnique Fédérale de Lausanne, Lausanne, Switzerland

  ⨯
• Liliane Glauser,

  Affiliation Brain Mind Institute, School of Life Sciences, Ecole Polytechnique Fédérale de Lausanne, Lausanne, Switzerland

  ⨯
• Andrew B. West,

  Affiliation Center for Neurodegeneration and Experimental Therapeutics, Department of Neurology, University of Alabama at Birmingham, Birmingham, Alabama, United States of America

  ⨯
• Rina Bandopadhyay,

  Affiliation Reta Lila Weston Institute of Neurological Disease, University College London Institute of Neurology, London, United Kingdom

  ⨯
• Darren J. Moore

  * E-mail: darren.moore@epfl.ch

  Affiliation Brain Mind Institute, School of Life Sciences, Ecole Polytechnique Fédérale de Lausanne, Lausanne, Switzerland

  ⨯